Variant report

Variant	esv3455552
Chromosome Location	chr21:45905527-45910449
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type
1	chr21:45902648..45905236-chr21:45906362..45908752,2	K562	blood:
2	chr21:45758851..45761192-chr21:45902340..45905536,3	K562	blood:
3	chr21:45908563..45910677-chr21:45919182..45922057,2	MCF-7	breast:
4	chr21:45905868..45907578-chr21:46240496..46242148,2	MCF-7	breast:
5	chr21:45758316..45760568-chr21:45903461..45906076,2	MCF-7	breast:
6	chr21:45722675..45723244-chr21:45907390..45907958,2	MCF-7	breast:

Variant related genes	Relation type
ENSG00000160226	chromatin interactions
ENSG00000232969	chromatin interactions

Extended variants
information (count: 186 )
Associated
traits (count: 101 )

Variant overlapped rSNPs/rCNVs (count:186 , 50 per page) page: 1 2 3 4

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs183130887	chr21:45905527-45905528	Active TSS Bivalent/Poised TSS Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs145609600	chr21:45905539-45905540	Active TSS Bivalent/Poised TSS Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs148472617	chr21:45905547-45905548	Active TSS Bivalent/Poised TSS Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs587657727	chr21:45905551-45905552	Active TSS Bivalent/Poised TSS Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs79239574	chr21:45905559-45905560	Active TSS Bivalent/Poised TSS Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs375021473	chr21:45905569-45905570	Active TSS Bivalent/Poised TSS Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs587597624	chr21:45905570-45905571	Active TSS Bivalent/Poised TSS Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs188612755	chr21:45905581-45905582	Active TSS Bivalent/Poised TSS Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs377176786	chr21:45905584-45905585	Active TSS Bivalent/Poised TSS Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs142710344	chr21:45905600-45905601	Active TSS Flanking Active TSS Bivalent/Poised TSS ZNF genes & repeats Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs587647709	chr21:45905616-45905617	Active TSS Flanking Active TSS Bivalent/Poised TSS ZNF genes & repeats Weak transcription Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs60289664	chr21:45905650-45905651	Active TSS Flanking Active TSS Bivalent/Poised TSS ZNF genes & repeats Weak transcription Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs587680655	chr21:45905675-45905676	Active TSS Flanking Active TSS Bivalent/Poised TSS ZNF genes & repeats Weak transcription Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs34702901	chr21:45905773-45905774	Active TSS Flanking Active TSS Bivalent/Poised TSS ZNF genes & repeats Weak transcription Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs587760328	chr21:45905807-45905808	Active TSS Flanking Active TSS Bivalent/Poised TSS ZNF genes & repeats Weak transcription Bivalent Enhancer Enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs8130704	chr21:45905872-45905873	Active TSS Flanking Active TSS Bivalent/Poised TSS ZNF genes & repeats Weak transcription Bivalent Enhancer Enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
17	rs147654515	chr21:45905882-45905883	Active TSS Flanking Active TSS Bivalent/Poised TSS ZNF genes & repeats Weak transcription Bivalent Enhancer Enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs587747696	chr21:45905905-45905906	Active TSS Flanking Active TSS Bivalent/Poised TSS ZNF genes & repeats Weak transcription Bivalent Enhancer Enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs587614885	chr21:45905919-45905920	Active TSS Flanking Active TSS Bivalent/Poised TSS ZNF genes & repeats Weak transcription Bivalent Enhancer Enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs142346322	chr21:45905922-45905923	Active TSS Flanking Active TSS Bivalent/Poised TSS ZNF genes & repeats Weak transcription Bivalent Enhancer Enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs587759700	chr21:45905969-45905970	Active TSS Flanking Active TSS Bivalent/Poised TSS ZNF genes & repeats Weak transcription Bivalent Enhancer Enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs75568612	chr21:45906002-45906003	Active TSS Enhancers Bivalent/Poised TSS ZNF genes & repeats Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs376871360	chr21:45906010-45906011	Active TSS Enhancers Bivalent/Poised TSS ZNF genes & repeats Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs587688012	chr21:45906032-45906033	Active TSS Enhancers Bivalent/Poised TSS ZNF genes & repeats Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs8131320	chr21:45906058-45906059	Active TSS Enhancers Bivalent/Poised TSS ZNF genes & repeats Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
26	rs587640493	chr21:45906063-45906064	Active TSS Enhancers Bivalent/Poised TSS ZNF genes & repeats Weak transcription Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs587641419	chr21:45906109-45906110	Active TSS Enhancers Bivalent/Poised TSS ZNF genes & repeats Weak transcription Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
28	rs587714001	chr21:45906125-45906126	Active TSS Enhancers Bivalent/Poised TSS ZNF genes & repeats Weak transcription Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
29	rs140912764	chr21:45906145-45906146	Active TSS Enhancers Bivalent/Poised TSS ZNF genes & repeats Weak transcription Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
30	rs587596302	chr21:45906157-45906158	Active TSS Enhancers Bivalent/Poised TSS ZNF genes & repeats Weak transcription Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
31	rs587643132	chr21:45906170-45906171	Active TSS Enhancers Bivalent/Poised TSS ZNF genes & repeats Weak transcription Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
32	rs77672928	chr21:45906189-45906190	Active TSS Enhancers Bivalent/Poised TSS ZNF genes & repeats Weak transcription Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
33	rs192273551	chr21:45906213-45906214	Active TSS Enhancers Bivalent/Poised TSS ZNF genes & repeats Weak transcription Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
34	rs587678672	chr21:45906230-45906231	Active TSS Enhancers Bivalent/Poised TSS ZNF genes & repeats Weak transcription Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
35	rs587758359	chr21:45906271-45906272	Active TSS Enhancers Bivalent/Poised TSS ZNF genes & repeats Weak transcription Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
36	rs587631535	chr21:45906280-45906281	Active TSS Enhancers Bivalent/Poised TSS ZNF genes & repeats Weak transcription Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
37	rs59181257	chr21:45906292-45906293	Active TSS Enhancers Bivalent/Poised TSS ZNF genes & repeats Weak transcription Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
38	rs184379108	chr21:45906310-45906311	Active TSS Enhancers Bivalent/Poised TSS ZNF genes & repeats Weak transcription Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
39	rs587742224	chr21:45906333-45906334	Active TSS Enhancers Bivalent/Poised TSS ZNF genes & repeats Weak transcription Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
40	rs189202699	chr21:45906364-45906365	Active TSS Enhancers Bivalent/Poised TSS ZNF genes & repeats Weak transcription Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
41	rs116042576	chr21:45906386-45906387	Active TSS Enhancers Bivalent/Poised TSS ZNF genes & repeats Weak transcription Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
42	rs587734627	chr21:45906420-45906421	Active TSS Weak transcription Bivalent/Poised TSS ZNF genes & repeats Flanking Active TSS Enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
43	rs192601995	chr21:45906478-45906479	Active TSS Weak transcription Bivalent/Poised TSS ZNF genes & repeats Flanking Active TSS Enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
44	rs147911504	chr21:45906491-45906492	Active TSS Weak transcription Bivalent/Poised TSS ZNF genes & repeats Flanking Active TSS Enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
45	rs587687572	chr21:45906501-45906502	Active TSS Weak transcription Bivalent/Poised TSS ZNF genes & repeats Flanking Active TSS Enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
46	rs184380862	chr21:45906585-45906586	Active TSS Weak transcription Bivalent/Poised TSS ZNF genes & repeats Flanking Active TSS Enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
47	rs150447639	chr21:45906587-45906588	Active TSS Weak transcription Bivalent/Poised TSS ZNF genes & repeats Flanking Active TSS Enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
48	rs587694526	chr21:45906596-45906597	Active TSS Weak transcription Bivalent/Poised TSS ZNF genes & repeats Flanking Active TSS Enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
49	rs189316269	chr21:45906598-45906599	Active TSS Weak transcription Bivalent/Poised TSS ZNF genes & repeats Flanking Active TSS Enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
50	rs587648542	chr21:45906610-45906611	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:101)

Disease	PMID	Source
Glioblastoma multiforme	21080181	CNVD
Cancer	16751803	CNVD
Medulloblastoma	21979893	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Down syndrome	17412756	CNVD
Down syndrome	17576883	CNVD
Acute promyelocytic leukemia	19109227	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	17387387	CNVD
Renal cell carcinoma	19461508	CNVD
Seminomas	18059402	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Prostate cancer	19156837	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
small cell lung cancer	20016488	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
lymphocytic leukemia	21291569	CNVD
Melanoma	18172304	CNVD
Autism	22958593	CNVD
Schizophrenia	22958593	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Wilms tumour	21544195	CNVD
Ewing''s sarcoma	17952124	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Acute myeloid leukemia	16864856	CNVD
Mental retardation	21031080	CNVD
Polymicrogyria	21031080	CNVD
periventricular nodular heterotopia	21031080	CNVD
Myelodysplastic syndrome	21606161	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Autism	18414403	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Breast cancer	21858162	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	17899364	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Prostate cancer	20473283	CNVD
Chordoma	18071362	CNVD
Glioblastoma multiforme	18628472	CNVD
Myelofibrosis	22110671	CNVD
Hirschsprung''s Disease	21712996	CNVD
Non-syndromic sensorineural hearing loss	17457615	CNVD
Ewing''s sarcoma	21437220	CNVD
Lung adenocarcinoma	17086460	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Ovarian neoplasms	16753589	CNVD
Non-small cell lung cancer	21829676	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Gastric adenocarcinoma	19115996	CNVD
Acute myeloid leukemia	21358987	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Prostate cancer	23341502	CNVD
Ovarian cancer	21720365	CNVD
Urothelial carcinoma	21177765	CNVD
Prostate cancer	18632612	CNVD
Acute myeloid leukemia	21251322	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
Cholangiocarcinoma	16830362	CNVD
Down syndrome	17334655	CNVD
Neuroticism	17667963	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Autoimmune polyendocrine syndrome	18200029	CNVD
Prostate cancer	19363497	CNVD
Lung cancer	17086460	CNVD
Olfactory neuroblastoma	18408657	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Multiple myeloma	16616336	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Breast cancer	21509527	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Breast cancer	17142309	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Acute myeloid leukemia	20729466	CNVD
Ewing''s sarcoma	18628472	CNVD
Leukemia	18628472	CNVD
small cell lung cancer	17426248	CNVD
Developmental delay	21147756	CNVD
Breast cancer	21364760	CNVD
Cancer	20164919	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:151 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr21:45881800-45911800	Weak transcription	Right Atrium	heart
2	chr21:45898600-45905600	Weak transcription	Breast Myoepithelial Primary Cells	Breast
3	chr21:45898800-45906200	Weak transcription	Spleen	Spleen
4	chr21:45901000-45916000	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
5	chr21:45905000-45905600	Flanking Active TSS	HepG2	liver
6	chr21:45905000-45905800	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
7	chr21:45905000-45905800	Flanking Active TSS	Liver	Liver
8	chr21:45905000-45906600	Active TSS	ES-I3 Cell Line	embryonic stem cell
9	chr21:45905000-45906600	Active TSS	Duodenum Smooth Muscle	Duodenum
10	chr21:45905000-45906600	Enhancers	Placenta	Placenta
11	chr21:45905200-45905600	Active TSS	H1 Cell Line	embryonic stem cell
12	chr21:45905200-45905600	Active TSS	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
13	chr21:45905200-45905600	Active TSS	Primary T helper naive cells fromperipheralblood	blood
14	chr21:45905200-45905600	Active TSS	Fetal Thymus	thymus
15	chr21:45905200-45905800	Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
16	chr21:45905200-45905800	Bivalent/Poised TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
17	chr21:45905200-45906200	Bivalent/Poised TSS	IMR90 fetal lung fibroblasts Cell Line	lung
18	chr21:45905200-45906200	Flanking Active TSS	Primary T cells from cord blood	blood
19	chr21:45905200-45906200	Active TSS	Adipose Nuclei	Adipose
20	chr21:45905200-45906400	Active TSS	ES-UCSF4 Cell Line	embryonic stem cell
21	chr21:45905200-45906400	Bivalent/Poised TSS	Fetal Adrenal Gland	Adrenal Gland
22	chr21:45905200-45906600	Bivalent/Poised TSS	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
23	chr21:45905200-45906600	Active TSS	H9 Derived Neuron Cultured Cells	ES cell derived
24	chr21:45905200-45906600	Active TSS	HUES6 Cell Line	embryonic stem cell
25	chr21:45905200-45906600	Active TSS	iPS DF 6.9 Cell Line	embryonic stem cell
26	chr21:45905200-45906600	Bivalent/Poised TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
27	chr21:45905200-45906600	Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
28	chr21:45905200-45906600	Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
29	chr21:45905200-45906600	Active TSS	A549	lung
30	chr21:45905200-45906800	Active TSS	H9 Cell Line	embryonic stem cell
31	chr21:45905400-45905600	Active TSS	iPS-15b Cell Line	embryonic stem cell
32	chr21:45905400-45905600	Active TSS	iPS-18 Cell Line	embryonic stem cell
33	chr21:45905400-45905600	Bivalent/Poised TSS	Primary monocytes fromperipheralblood	blood
34	chr21:45905400-45905600	Bivalent/Poised TSS	Primary B cells from peripheral blood	blood
35	chr21:45905400-45905600	Flanking Bivalent TSS/Enh	Primary T cells fromperipheralblood	blood
36	chr21:45905400-45905600	Active TSS	Primary T helper cells PMA-I stimulated	--
37	chr21:45905400-45905600	Bivalent/Poised TSS	Foreskin Melanocyte Primary Cells skin01	Skin
38	chr21:45905400-45905600	Flanking Active TSS	Lung	lung
39	chr21:45905400-45905800	Active TSS	Primary T helper cells fromperipheralblood	blood
40	chr21:45905400-45905800	Active TSS	Primary T regulatory cells fromperipheralblood	blood
41	chr21:45905400-45905800	Active TSS	Primary T killer naive cells fromperipheralblood	blood
42	chr21:45905400-45905800	Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
43	chr21:45905400-45905800	Active TSS	Fetal Kidney	kidney
44	chr21:45905400-45905800	Bivalent/Poised TSS	Fetal Muscle Trunk	muscle
45	chr21:45905400-45905800	Bivalent/Poised TSS	Fetal Muscle Leg	muscle
46	chr21:45905400-45905800	Active TSS	Ovary	ovary
47	chr21:45905400-45906000	Active TSS	Brain Germinal Matrix	brain
48	chr21:45905400-45906000	Active TSS	Fetal Intestine Small	intestine
49	chr21:45905400-45906000	Bivalent/Poised TSS	Stomach Smooth Muscle	stomach
50	chr21:45905400-45906000	Active TSS	Osteobl	bone

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links